Circassia
Oxford
About Circassia
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $156.5M
- Funding stage: IPO
- Last round: Series D (Apr 2011)
- Ticker: lse:CIR
- Website: circassia.com
- Phone: +4401865405560
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/circassia-1534112 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.